Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
呼吸器疾患の治療
Document Type and Number:
Japanese Patent JP5042426
Kind Code:
B2
Abstract:
The present invention provides a pharmaceutical composition comprising glycopyrrolate as an inhalable dry powder formulation, said dry powder optionally further comprising an excipient, said formulation permitting the glycopyrrolate to exert its pharmacological effect over a period greater than 12 hours, for use in the treatment of chronic obstructive pulmonary disease (COPD).

Inventors:
Banister, robin, mark
Richards, Andrew, John, McGrathhan
Gilbert, Julian, Clive
Morton, David, A, Buoy
Stani Force, John
Application Number:
JP2001574093A
Publication Date:
October 03, 2012
Filing Date:
April 09, 2001
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Sosei R&D Limited
International Classes:
A61K9/72; A61K9/00; A61K9/12; A61K9/14; A61K9/16; A61K31/00; A61K31/40; A61K31/4015; A61K31/46; A61K38/00; A61K45/00; A61K45/06; A61K47/12; A61K47/36; A61L9/04; A61P11/06; A61P35/00; A61P43/00
Domestic Patent References:
JP11501937A
JP2002529498A
Foreign References:
WO1998031346A1
WO1997039758A1
WO2000006121A1
Other References:
WALKER,F.B. et al,Prolonged effect of inhaled glycopyrrolate in asthma,Chest,1987年,Vol.91, No.1,p.49-51
SCHROECKENSTEIN,D.C. et al,Twelve-hour bronchodilation in asthma with a single aerosol dose of the anticholinergic compound glycopyrrolate,J Allergy Clin Immunol,1988年,Vol.82, No.1,p.115-119
TZELEPIS,G. et al,Comparison of nebulized glycopyrrolate and metaproterenol in chronic obstructive pulmonary disease,Eur Respir J,1996年,Vol.9, No.1,p.100-103
Attorney, Agent or Firm:
Shohei Oguri
Hironori Honda
Toshimitsu Ichikawa



 
Previous Patent: JPS5042425

Next Patent: JPS5042427